Warfarin or dabigatran for treatment of atrial fibrillation-Reference-Cited by-同舟云学术

Warfarin or dabigatran for treatment of atrial fibrillation

Published:2014-06-19 Issue:7 Volume:12 Page:1193-1195
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Poller L.¹,Jespersen J.²,Ibrahim S.¹,

Affiliation:

1. European Action on Anticoagulation (EAA) Central Facility; Faculty of Life Sciences; University of Manchester; Manchester UK

2. Department of Clinical Biochemistry; Hospital of South West Denmark; Esbjerg, and Department for Thrombosis Research; Institute of Public Health; University of Southern Denmark; Esbjerg Denmark

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12590/fullpdf

Reference17 articles.

1. An international multicentre study of computer assisted oral anticoagulant dosage versus medical staff;Poller;J Thromb Haemost,2008

2. Guidelines for thromboplastin and plasmas used to control oral anticoagulant therapy;Besselaar;World Health Organ Tech Rep Ser,1999

3. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

4. Simplified method for international normalised ratio (INR) derivation based on the prothrombin time/INR Line. An International Study;Poller;Clin Chem,2010

5. European Action on anticoagulation. The prothrombin time /international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers - two independent studies;Poller;J Thromb Haemost,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can clinical pharmacists utilize telehealth to double the safety and efficacy of oral anticoagulation while reducing health care costs and improving patient satisfaction in patients with atrial fibrillation?;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2021-06-22

2. Oral anticoagulant monitoring: Are we on the right track?;International Journal of Laboratory Hematology;2019-05

3. Effectiveness and safety of vitamin K-antagonists in an anticoagulant clinic;Thrombosis Research;2016-11

4. Sex Differences in Treatment Quality of Self-Managed Oral Anticoagulant Therapy: 6,900 Patient-Years of Follow-Up;PLoS ONE;2014-11-21

5. Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays;Thrombosis Journal;2014-11-04